Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,284 across all filing types
Latest filing 2025-07-30 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
关于转让控股子公司股权暨募投项目转让的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of a transaction involving the transfer of controlling subsidiary equity and related fundraising project transfer. It details the transaction overview, shareholder meeting approvals, updated shareholding structure, and the impact on the company. The document is relatively short (999 characters) and focuses on reporting the status and impact of a capital transaction rather than providing full financial statements or detailed financial analysis. It does not contain comprehensive financial data or audit information. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2025-07-30 Chinese
关于获得兽用生物制品临床试验批件的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by 瑞普生物股份有限公司 regarding the receipt of a clinical trial approval for a veterinary biological product (an mRNA vaccine for porcine epidemic diarrhea virus). It includes details about the approval, the nature of the disease, the vaccine's advantages, and the potential impact and risks for the company. The document is relatively short (1071 characters) and serves as an official announcement of a regulatory approval rather than a detailed financial or operational report. It does not contain financial statements, management discussion, or detailed investor presentation content. It is not a report publication announcement since it does not mention any report being attached or published. The content fits best under a Regulatory Filings (RNS) category as it is a regulatory announcement about clinical trial approval, which is a compliance-related disclosure.
2025-07-25 Chinese
2025年半年度业绩预告
Earnings Release Classification · 95% confidence The document is a 2025 half-year performance forecast (业绩预告) for the period January 1 to June 30, 2025. It contains preliminary estimated financial results such as net profit and profit growth percentages, but explicitly states that the data is unaudited and preliminary, and that the final audited data will be in the 2025 half-year report. The document is short (1517 characters) and serves as a forecast or earnings preview rather than a full interim/quarterly report with actual financial statements or detailed analysis. Therefore, it fits the definition of an Earnings Release (ER) as an initial announcement of periodical financial results with key highlights only, rather than a full Interim Report (IR). H1 2025
2025-07-14 Chinese
关于持股5%以上股东梁武持股拟在一致行动人之间内部转让的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding an internal transfer of shares between a shareholder holding more than 5% and their concerted parties. It details the shareholder's name, shareholding percentages before and after the transfer, the reason for transfer (family asset planning), and confirms that the total shareholding percentage remains unchanged. There is no financial data, earnings information, or report attached. The document is a notification of a major shareholding change (internal transfer) but does not indicate a change in control or governance. This fits the definition of a Major Shareholding Notification (MRQ). The document length is short and focused solely on shareholding changes, not a full report or announcement of a report publication.
2025-07-11 Chinese
关于2022年限制性股票激励计划部分限制性股票回购注销完成工商变更登记的公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the completion of the repurchase and cancellation of restricted shares under the 2022 restricted stock incentive plan, including the related change in the company's registered capital and business license update. It does not contain financial statements or detailed financial data, nor is it a report or presentation. It is a formal announcement about a capital change event (share repurchase and cancellation) and related registration update. Therefore, it fits best under the category of Share Issue/Capital Change (SHA). The document length is short and focused on the capital change event, not a full report or regulatory filing.
2025-07-11 Chinese
关于控股股东及其一致行动人持股比例因公司注销回购股份被动增加触及1%的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding a change in shareholding percentages due to the company's repurchase and cancellation of restricted stock shares. It details the passive increase in the controlling shareholder's stake, the number of shares before and after the change, and confirms no change in control or governance structure. The content focuses on shareholding notifications and changes in significant ownership levels, specifically mentioning crossing a 1% threshold. There are no financial statements, earnings data, or management discussions. This fits the definition of a Major Shareholding Notification (MRQ). The document length is short and it is not a report publication or certification, so it is not RPA or RNS.
2025-07-11 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.